Source:http://linkedlifedata.com/resource/pubmed/id/11335909
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
9
|
pubmed:dateCreated |
2001-5-3
|
pubmed:abstractText |
Metastatic melanoma developing in patients with a level 2 primary cutaneous malignant melanoma (CMM) is rare but has been reported in studies with follow-up periods ranging up to 15 years. The objective of this study was to investigate level 2 CMM associated with metastasis in a population-based retrospective study.
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:status |
MEDLINE
|
pubmed:month |
May
|
pubmed:issn |
0008-543X
|
pubmed:author | |
pubmed:copyrightInfo |
Copyright 2001 American Cancer Society.
|
pubmed:issnType |
Print
|
pubmed:day |
1
|
pubmed:volume |
91
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1822-5
|
pubmed:dateRevised |
2004-11-17
|
pubmed:meshHeading |
pubmed-meshheading:11335909-Humans,
pubmed-meshheading:11335909-Melanoma,
pubmed-meshheading:11335909-Neoplasm Invasiveness,
pubmed-meshheading:11335909-Neoplasm Metastasis,
pubmed-meshheading:11335909-Neoplasm Staging,
pubmed-meshheading:11335909-Prognosis,
pubmed-meshheading:11335909-Retrospective Studies
|
pubmed:year |
2001
|
pubmed:articleTitle |
Clinical and histologic features of level 2 cutaneous malignant melanoma associated with metastasis.
|
pubmed:affiliation |
Department of Pathology, University of Western Australia, Queen Elizabeth II Medical Centre, Nedlands, Western Australia. pheenan@cyllene.uwa.edu.au
|
pubmed:publicationType |
Journal Article
|